Health Condition 1: null- Subjects who have clinical symptoms of dyspepsia, upper abdominal pain, heart burn, bloating, indigestion, flatulence, abdominal distension, belching and fullness after meal
Conditions
Interventions
Intervention1: GastriCare A: 1 capsule of GastriCare A thrice daily
Control Intervention1: GastriCare B: 1 capsule of GastriCare B thrice daily
Sponsors
The Himalaya Drug Company
Eligibility
Inclusion criteria
Inclusion criteria: 1 Subjects of both sexes in the age group of 18 - 60 years, with gastric problems. 2 Subjects who have clinical symptoms of dyspepsia, upper abdominal pain, heart burn, bloating, indigestion, flatulence, abdominal distension, belching and fullness after meal. 3 Subjects willing to give written informed consent. 4 Subjects who have not participated in similar kind of study in last 4 weeks.
Exclusion criteria
Exclusion criteria: 1 Subjects with established hypertension, renal, hepatic or cardiac failure 2 Endocrine disorders 3 Use of prescription medication to treat gastric problems 4 Pregnant & lactating women. 5 Not willing to sign informed consent form.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical improvement in the overall health as assessed by clinical examination of signs and symptoms such as epigastric discomfort, heartburn, Nausea, vomiting, belching, flatulence, fullness in the stomach, abdominal distension and the points mentioned in questionnaireTimepoint: baseline, 2nd week and 4th week | — |
Secondary
| Measure | Time frame |
|---|---|
| Compliance of the subject to the drug treatment and the adverse effects will be notedTimepoint: baseline and 4th week | — |
Countries
India
Contacts
Public ContactDr Bindumathi PL MBBS MD
Sapthagiri Institute of Medical Sciences and Research Centre
Outcome results
None listed